Store

Home
Xellia Pharmaceuticals USA LLC
Bedford Feb 2022 483

483 Document: Xellia Pharmaceuticals USA LLC, Feb 7, 2022

Lisa R. Hilliard, FDA Investigator
Andrew J. Barrowcliff, FDA Investigator

FDANews 483 Xellia Pharmaceuticals USA LLC Feb 7 2022 top

Lisa R. Hilliard FDA Investigator Andrew J. Barrowcliff FDA Investigator

On Feb 07, 2022, the FDA inspected Xellia Pharmaceuticals USA LLC's Bedford site. Explore the inspectional observations.

Xellia Pharmaceuticals USA LLC

483 Document

Issued: Feb 7, 2022

Details

Human DrugInspection
Bedford / United States
15 days

Available for Download - $199

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Clinical Trials Analytics

Clincosm

Marketplace connecting patients to clinical trials to accelerate patient recruitment is accelerating medicine

Productivity

CalendarCrush

App for calendar-driven people to account and bill for their time

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2024 Zymergi, Inc.